Aurobindo Pharma's Unit 1 receives USFDA observations: Report

21 Dec 2016 Evaluate

The US Food and Drug Administration (USFDA) has reportedly issued Form 483 observations against Unit I of Aurobindo Pharma in Hyderabad, India. The plant is used for manufacturing of active pharmaceutical ingredients (APIs), which contribute little over 20% of the company's total revenues.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1172.75 -8.45 (-0.72%)
01-Jan-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.55
Dr. Reddys Lab 1254.70
Cipla 1503.65
Zydus Lifesciences 908.85
Lupin 2084.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×